EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non‐valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study

Non‐vitamin K antagonists oral anticoagulants (NOACs) have recently challenged vitamin‐K antagonists (VKAs) for stroke and systemic embolism prophylaxis in patients with non‐valvular atrial fibrillation (NVAF). Nevertheless, little information is available in routine clinical practice for France. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Picard, Fabien, Van Ganse, Eric, Ducrocq, Gregory, Danchin, Nicolas, Falissard, Bruno, Hanon, Olivier, Belhassen, Manon, Ginoux, Marine, Lefevre, Cinira, Cotte, François‐Emery, Mahé, Isabelle, Steg, Philippe G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Trial Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788467/
https://www.ncbi.nlm.nih.gov/pubmed/31313832
http://dx.doi.org/10.1002/clc.23231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788467/
https://www.ncbi.nlm.nih.gov/pubmed/31313832
http://dx.doi.org/10.1002/clc.23231

Ejemplares similares